1533 related articles for article (PubMed ID: 31695329)
21. Predict drug permeability to blood-brain-barrier from clinical phenotypes: drug side effects and drug indications.
Gao Z; Chen Y; Cai X; Xu R
Bioinformatics; 2017 Mar; 33(6):901-908. PubMed ID: 27993785
[TBL] [Abstract][Full Text] [Related]
22. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
Shawahna R; Decleves X; Scherrmann JM
Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in blood-brain barrier disruption as a CNS delivery strategy.
Bellavance MA; Blanchette M; Fortin D
AAPS J; 2008; 10(1):166-77. PubMed ID: 18446517
[TBL] [Abstract][Full Text] [Related]
24. Drug delivery to brain via the blood-brain barrier.
Scherrmann JM
Vascul Pharmacol; 2002 Jun; 38(6):349-54. PubMed ID: 12529929
[TBL] [Abstract][Full Text] [Related]
25. Blood-brain barrier: structural components and function under physiologic and pathologic conditions.
Persidsky Y; Ramirez SH; Haorah J; Kanmogne GD
J Neuroimmune Pharmacol; 2006 Sep; 1(3):223-36. PubMed ID: 18040800
[TBL] [Abstract][Full Text] [Related]
26. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
[TBL] [Abstract][Full Text] [Related]
27. Advances in microphysiological blood-brain barrier (BBB) models towards drug delivery.
Lee CS; Leong KW
Curr Opin Biotechnol; 2020 Dec; 66():78-87. PubMed ID: 32711361
[TBL] [Abstract][Full Text] [Related]
28. New experimental models of the blood-brain barrier for CNS drug discovery.
Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
[TBL] [Abstract][Full Text] [Related]
29. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
Feng S; Huang Y; Chen Z
Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
[TBL] [Abstract][Full Text] [Related]
30. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
31. Zebrafish: A promising in vivo model for assessing the delivery of natural products, fluorescence dyes and drugs across the blood-brain barrier.
Li Y; Chen T; Miao X; Yi X; Wang X; Zhao H; Lee SM; Zheng Y
Pharmacol Res; 2017 Nov; 125(Pt B):246-257. PubMed ID: 28867638
[TBL] [Abstract][Full Text] [Related]
32. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
Kristensen M; Brodin B
J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
[TBL] [Abstract][Full Text] [Related]
33. Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview.
Song YH; De R; Lee KT
Adv Colloid Interface Sci; 2023 Oct; 320():103008. PubMed ID: 37776736
[TBL] [Abstract][Full Text] [Related]
34. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
[TBL] [Abstract][Full Text] [Related]
35. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
Crawford L; Rosch J; Putnam D
J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
[TBL] [Abstract][Full Text] [Related]
36. Model systems for studying the blood-brain barrier: Applications and challenges.
Jackson S; Meeks C; Vézina A; Robey RW; Tanner K; Gottesman MM
Biomaterials; 2019 Sep; 214():119217. PubMed ID: 31146177
[TBL] [Abstract][Full Text] [Related]
37. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review.
Bicker J; Alves G; Fortuna A; Falcão A
Eur J Pharm Biopharm; 2014 Aug; 87(3):409-32. PubMed ID: 24686194
[TBL] [Abstract][Full Text] [Related]
38. Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier.
Wang JZ; Xiao N; Zhang YZ; Zhao CX; Guo XH; Lu LM
Pharmacol Res; 2016 Feb; 104():124-31. PubMed ID: 26747400
[TBL] [Abstract][Full Text] [Related]
39. In vitro blood brain barrier models: An overview.
Jagtiani E; Yeolekar M; Naik S; Patravale V
J Control Release; 2022 Mar; 343():13-30. PubMed ID: 35026351
[TBL] [Abstract][Full Text] [Related]
40. Experimental methods and transport models for drug delivery across the blood-brain barrier.
Fu BM
Curr Pharm Biotechnol; 2012 Jun; 13(7):1346-59. PubMed ID: 22201587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
